The global organ transport devices market size is expected to be worth US$ 115.1 Million in 2022 and to grow at an 8.7% CAGR during the forecast period (2022 to 2032). The global market is expected to be worth US$ 265.1 million by the end of 2032.
Healthcare services and quality of care have improved as a result of technological advancements in the sector. Rising demand for organ transplantation is projected to drive research and development activities, as well as investments in new organ care products.
Get a Sample Copy of Report PDF@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15180
For instance, in April 2021, TransMedics Group Inc. launched ‘Heart in a Box’ or the Transmedics Organ Care System (OCS) Heart. The portable organ care device can preserve and monitor hearts donated for transplant for up to three times longer than current methods.
Furthermore, to meet the increased need for organ transplantation, various bioengineering organizations are performing research and development activities. Governments are also providing funds to these companies to accelerate research work.
In July 2022, for instance, researchers from various institutions across the globe announced that the U.S. FDA may soon allow them to perform clinical trials that would involve transplantation of pig organs into humans. Therefore, rising number of clinical trials by key players is set to help the global organ transport devices market to reach US$ 265.1 Million in 2032.
Moreover, key players operating in the industry are focusing on expanding their geographic presence by strengthening their distribution networks, initiating promotional activities, and enhancing customer services for the betterment of the brand and products. It would further push the organ transport devices market during the upcoming decade.
Key Takeaways: Organ Transport Devices Market
- By product, the cold or hypothermic perfusion devices segment held nearly 63.7% of the market share in 2021 and is expected to showcase a CAGR of 9.2% in 2022-2032.
- By organ, the kidney segment held about 62.0% of the market share in 2021 and is expected to exhibit a CAGR of 8.5% over the forecast period.
- By end user, transplant centers held the highest organ transport devices market share of around 67.4% in 2021.
- The U.S. organ transport devices market generated a robust share of approximately 92.4% in 2021.
- North America is considered to be the leading region and held a share of 36.9% in 2021 in the organ transport devices market.
For any Queries Linked with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-15180
“Increasing procedural rate of organ transplantation and urgent need for organ transplantation procedures are projected to boost the global organ transport devices market share,” says an analyst of Future Market Insights.
Competitive Landscape: Organ Transport Devices Market
- TransMedics Inc.
- Paragonix Technologies
- Organ Recovery Systems
- XVIVO Perfusion AB
- OrganOx Limited
- X-Therma Inc
- Others
Some of the latest developments in the global organ transport devices market are:
- In December 2021, the University of Nebraska collaborated with Paragonix Technologies, a leading provider of donor organ preservation and transport systems, to boost organ donor reserves.
- In July 2021, Carolina Donor Services and TransMedics collaborated to develop a national organ care system that expands the number of lungs available for transplant. With this system, the lungs can be transported at a long distance and can save many lives.
- In January 2022, EBERS Medical Technology SL. won the tender to build a new generation of ex vivo normothermic perfusion system.
More Valuable Insights on Organ Transport Devices Market:
Future Market Insights brings a comprehensive research report on forecast revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the segments from 2017 to 2032. The global organ transport devices market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
The study provides compelling insights on the organ transport devices market segment based on product (warm or normothermic perfusion devices and cold or hypothermic perfusion devices), organ (liver, heart, kidney, lung, and others), and end user (hospitals, transplant centers, and ambulatory surgical centers) across seven major regions.
Buy Now@ https://www.futuremarketinsights.com/checkout/15180
Organ Transport Devices Market Outlook by Category
By Product:
- Warm or Normothermic Perfusion Devices
- Cold or Hypothermic Perfusion Devices
By Organ:
- Liver
- Heart
- Kidney
- Lung
- Others (Pancreas, Small Intestine)
By End User:
- Hospitals
- Transplant Centers
- Ambulatory Surgical Centers
About Future Market Insights, Inc.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
